3Amercan diabetes assolition. Report of the expert committee on the diagnosis and classification of diabetes mellitus J. Diabetes care, 1997,20:1183-1187.
4Costa A·lguala I,Dedini J,et al. Uric acid concectration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabloic symdrome. Metobolism,2002,51 (3):372-5.
5Ma RM, Lao TT. Maternal mean arterial pressurt and oral glucose tolerance test results. Relationship in normotensive women. J Repord Med ,2001,16(8): 747-51.
6Estrada Vicente. Serrano Rios Manuel, Martinez Larrad, Maria Teresa,et al. Leptin and adipose tissue maidistribution in HIV- infected male patients with predominant fat loss treated with antiretroviral therapy. J Acquir Immune Defic Symdr. 2002,29(1):32 40.
7Li Chia Lin, Tsal Shih Tzer. Chou Pesus. Comparion of metabolic risk profiles between subjects with fasting and 2 - hour plasma glucose impairment : The Kinmen Study. J Clin Epidemiol,2002,55(1):9-24.
8Tamas G, Kerenyi Z. Gestational diabetes: current aspects on pathogenesis and treatment. Exp Clin Endocrinol Diabetes, 2001.109 Suppl 2:S400-11.
9Kudolo GB. The effect of 3-month ingestion of ginkgo biloba extract(Egb 761) on pancreatic beta-cell function in response to glucose loading in individuals withnon-insulin - dependent diabetes mellitus. J - Clin - Pharmacol,2001.41(6) :600-11.
10Report of the expert committee on the diagnosis and classification of diabetes mellitus.Diabetes Care,2002,25(Suppl 1):S5-S20.
